An autologous stem-cell treatment for patients with damaged heart muscle following an acute myocardial infarction has resulted in improved perfusion, a trend towards improved cardiac function, that was dose dependent, according to US research.
An autologous stem-cell treatment for patients with damaged heart muscle following an acute myocardial infarction has resulted in improved perfusion, a trend towards improved cardiac function, that was dose dependent, according to US research.